Dr. Karl Butterworth of Queen’s University Belfast recently shared about his experience using SARRP for research as part of a SARRP panel. In this clip, you can hear the highlights of their biology research program, including future opportunities.
CIX3 used in HER2-positive Tumor Research
See what researchers found in the recent study: Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2‑positive murine tumor. See the original publication here.
